Coronavirus outbreak fuels concerns about pharma's global supply chain
The spread of the coronavirus in China has raised concerns about the pharmaceutical industry's global supply chain, STAT reports.
Between the lines: China produces a large portion of the ingredients used to make drugs. As the coronavirus spreads and sends China increasingly into lockdown, it's causing experts to question whether the supply chain is stable.
By the numbers: 13% of all facilities that make ingredients for drugs sold in the U.S. are located in China, and 85% of medicines in the U.S. strategic national stockpile use some component that comes from China.
Yes, but: Most drugmakers have more than one supplier for the ingredients they need for each medicine.